Somerset Trust Co trimmed its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.6% in the third quarter, according to its ...

Cwm LLC boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.7% during the 3rd quarter, according to the ...

The fact that multiple Amgen Inc. ( NASDAQ:AMGN ) insiders offloaded a considerable amount of shares over the past ...

Amgen Inc. closed $29.40 below its 52-week high ($346.85), which the company reached on July 25th.

We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Amgen ...

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic ...

Barclays analyst Carter Gould maintained a Hold rating on Amgen (AMGN – Research Report) on October 4 and set a price target of $315.00.

On Monday, Amgen Inc (AMGN) stock saw a decline, ending the day at $317.45 which represents a decrease of $-2.21 or -0.69% from the prior close of $319.66. The stock opened at $320.08 and touched a ...

The companies will collaborate to hold a global Phase I combination trial of YL201 and Amgen’s Imdelltra for small cell lung ...

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human ...

About Amgen Inc and Sanofi SA (ADR) Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, ...

Amgen (AMGN) closed at $328.35 on Friday, 2.29% higher on the day. Amgen's stock price has increased 14.00% so far this year, ...